Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Cardiac dysfunction occurs in the HIV-1 transgenic mouse treated with zidovudine.

Lewis W, Grupp IL, Grupp G, Hoit B, Morris R, Samarel AM, Bruggeman L, Klotman P.

Lab Invest. 2000 Feb;80(2):187-97.

2.

The effect of isoproterenol on phospholamban-deficient mouse hearts with altered thyroid conditions.

Brittsan AG, Kiss E, Edes I, Grupp IL, Grupp G, Kranias EG.

J Mol Cell Cardiol. 1999 Sep;31(9):1725-37.

PMID:
10471356
3.

Identification of a specific role for the Na,K-ATPase alpha 2 isoform as a regulator of calcium in the heart.

James PF, Grupp IL, Grupp G, Woo AL, Askew GR, Croyle ML, Walsh RA, Lingrel JB.

Mol Cell. 1999 May;3(5):555-63.

4.

Protection against hypoxia-reoxygenation in the absence of poly (ADP-ribose) synthetase in isolated working hearts.

Grupp IL, Jackson TM, Hake P, Grupp G, Szabó C.

J Mol Cell Cardiol. 1999 Jan;31(1):297-303.

PMID:
10072736
5.

Targeted overexpression of the sarcoplasmic reticulum Ca2+-ATPase increases cardiac contractility in transgenic mouse hearts.

Baker DL, Hashimoto K, Grupp IL, Ji Y, Reed T, Loukianov E, Grupp G, Bhagwhat A, Hoit B, Walsh R, Marban E, Periasamy M.

Circ Res. 1998 Dec 14-28;83(12):1205-14.

PMID:
9851937
6.

Enhanced myocardial contractility and increased Ca2+ transport function in transgenic hearts expressing the fast-twitch skeletal muscle sarcoplasmic reticulum Ca2+-ATPase.

Loukianov E, Ji Y, Grupp IL, Kirkpatrick DL, Baker DL, Loukianova T, Grupp G, Lytton J, Walsh RA, Periasamy M.

Circ Res. 1998 Nov 2;83(9):889-97.

PMID:
9797337
7.

Thyroid hormone-induced alterations in phospholamban-deficient mouse hearts.

Kiss E, Brittsan AG, Edes I, Grupp IL, Grupp G, Kranias EG.

Circ Res. 1998 Sep 21;83(6):608-13.

PMID:
9742056
8.

Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heart.

Jones WK, Grupp IL, Doetschman T, Grupp G, Osinska H, Hewett TE, Boivin G, Gulick J, Ng WA, Robbins J.

J Clin Invest. 1996 Oct 15;98(8):1906-17.

9.

Reduction of Carnitine Content by Inhibition of Its Biosynthesis Results in Protection of Isolated Guinea Pig Hearts Against Hypoxic Damage.

Dhar PK, Grupp IL, Schwartz A, Grupp G, Matlib MA.

J Cardiovasc Pharmacol Ther. 1996 Jul;1(3):235-242.

PMID:
10684422
10.

Phospholamban gene dosage effects in the mammalian heart.

Luo W, Wolska BM, Grupp IL, Harrer JM, Haghighi K, Ferguson DG, Slack JP, Grupp G, Doetschman T, Solaro RJ, Kranias EG.

Circ Res. 1996 May;78(5):839-47.

PMID:
8620604
11.

Molecular and physiological effects of overexpressing striated muscle beta-tropomyosin in the adult murine heart.

Muthuchamy M, Grupp IL, Grupp G, O'Toole BA, Kier AB, Boivin GP, Neumann J, Wieczorek DF.

J Biol Chem. 1995 Dec 22;270(51):30593-603.

12.

Remodeling the mammalian heart using transgenesis.

Palermo J, Gulick J, Ng W, Grupp IL, Grupp G, Robbins J.

Cell Mol Biol Res. 1995;41(6):501-9.

PMID:
8777429
13.

Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation.

Luo W, Grupp IL, Harrer J, Ponniah S, Grupp G, Duffy JJ, Doetschman T, Kranias EG.

Circ Res. 1994 Sep;75(3):401-9.

PMID:
8062415
14.

Alpha-skeletal actin is associated with increased contractility in the mouse heart.

Hewett TE, Grupp IL, Grupp G, Robbins J.

Circ Res. 1994 Apr;74(4):740-6.

PMID:
8137509
15.

Vesnarinone for heart failure.

Schwartz A, Grupp I, Grupp G.

N Engl J Med. 1994 Jan 6;330(1):65; author reply 66. No abstract available. Erratum in: N Engl J Med 1994 Mar 31;330(13):947.

PMID:
8259153
16.

Characterisation of Na/K-ATPase, its isoforms, and the inotropic response to ouabain in isolated failing human hearts.

Shamraj OI, Grupp IL, Grupp G, Melvin D, Gradoux N, Kremers W, Lingrel JB, De Pover A.

Cardiovasc Res. 1993 Dec;27(12):2229-37.

PMID:
8313433
17.

Comparison of normal, hypodynamic, and hyperdynamic mouse hearts using isolated work-performing heart preparations.

Grupp IL, Subramaniam A, Hewett TE, Robbins J, Grupp G.

Am J Physiol. 1993 Oct;265(4 Pt 2):H1401-10.

PMID:
7694487
18.

Cardiac glycosides in the treatment of experimental overdose with calcium-blocking agents.

Ramo MP, Grupp I, Pesola MK, Heikkila J, Luomanmaki K, Schroder T, Grupp G.

Res Exp Med (Berl). 1992;192(5):335-43.

PMID:
1439198
19.

Contractile effects of cardiac neuropeptides in isolated canine atrial and ventricular muscles.

Rigel DF, Grupp IL, Balasubramaniam A, Grupp G.

Am J Physiol. 1989 Oct;257(4 Pt 2):H1082-7.

PMID:
2801971
20.
21.

Role of the Na+K+-ATPase in the cardiotonic action of cardiac glycosides.

Schwartz A, Grupp G, Wallick E, Grupp IL, Ball WJ Jr.

Prog Clin Biol Res. 1988;268B:321-38. Review.

PMID:
2851810
22.

The calcium dependence of the biphasic inotropic response to ouabain in the isolated rat heart.

Hickerson TW, Grupp IL, Schwartz A, Grupp G.

Prog Clin Biol Res. 1988;258:223-34.

PMID:
2837773
23.
24.

Vasodilatory action of amlodipine on rat aorta, pig coronary artery, human coronary artery, and on isolated Langendorff rat heart preparations.

Matlib MA, French JF, Grupp IL, Van Gorp C, Grupp G, Schwartz A.

J Cardiovasc Pharmacol. 1988;12 Suppl 7:S50-4.

PMID:
2467129
25.

Selective updates on mechanisms of action of positive inotropic agents.

Grupp G.

Mol Cell Biochem. 1987 Aug;76(2):97-112. Review.

PMID:
2823098
26.
27.

Hemodynamic and electrophysiological effects of a novel positive inotropic drug, OPC-8212, in normal and "failing" guinea pig heart preparations.

Grupp G, Grupp IL, Kojima M, Sperelakis N, Tsuchiya Y, Hosokawa T, Schwartz A.

J Cardiovasc Pharmacol. 1986 Mar-Apr;8(2):428-40.

PMID:
2422485
28.

Myocardial actions of milrinone: characterization of its mechanism of action.

Rapundalo ST, Grupp I, Grupp G, Abdul Matlib M, Solaro RJ, Schwartz A.

Circulation. 1986 Mar;73(3 Pt 2):III134-44.

PMID:
2417746
29.

Reversibility of inotropic effects of ouabain on canine atrial and ventricular tissues.

Grupp G, Grupp IL, Schwartz A.

J Mol Cell Cardiol. 1985 Nov;17(11):1077-84.

PMID:
4078906
30.

Profile of the oppositely acting enantiomers of the dihydropyridine 202-791 in cardiac preparations: receptor binding, electrophysiological, and pharmacological studies.

Williams JS, Grupp IL, Grupp G, Vaghy PL, Dumont L, Schwartz A, Yatani A, Hamilton S, Brown AM.

Biochem Biophys Res Commun. 1985 Aug 30;131(1):13-21.

PMID:
2412552
31.

Effects of dihydropyridine calcium channel modulators in the heart: pharmacological and radioligand binding correlations.

Schwartz A, Grupp IL, Grupp G, Williams JS, Vaghy PL.

Biochem Biophys Res Commun. 1984 Nov 30;125(1):387-94.

PMID:
6210085
33.

Correlation of nitrendipine and Bay k 8644 binding to isolated canine heart sarcolemma with their pharmacological effects on the canine heart.

Vaghy PL, Grupp IL, Grupp G, Balwierczak JL, Williams JS, Schwartz A.

Eur J Pharmacol. 1984 Jul 13;102(2):373-4. No abstract available.

PMID:
6207033
34.

Analysis of the inotropic action of ouabain in rat ventricles: two apparent ouabain inotropic responses.

Grupp G, DePover A, Grupp IL, Schwartz A.

Proc Soc Exp Biol Med. 1984 Jan;175(1):39-43.

PMID:
6694968
36.

Diltiazem potentiates the negative inotropic action of nimodipine in heart.

DePover A, Grupp IL, Grupp G, Schwartz A.

Biochem Biophys Res Commun. 1983 Aug 12;114(3):922-9.

PMID:
6615515
37.
38.

Specific binding of [3H]nitrendipine to membranes from coronary arteries and heart in relation to pharmacological effects. Paradoxical stimulation by diltiazem.

DePover A, Matlib MA, Lee SW, Dubé GP, Grupp IL, Grupp G, Schwartz A.

Biochem Biophys Res Commun. 1982 Sep 16;108(1):110-7. No abstract available.

PMID:
6293474
39.

High-affinity ouabain binding site and low-dose positive inotropic effect in rat myocardium.

Adams RJ, Schwartz A, Grupp G, Grupp I, Lee SW, Wallick ET, Powell T, Twist VW, Gathiram P.

Nature. 1982 Mar 11;296(5853):167-9. No abstract available.

PMID:
6278317
40.

Differential cardiovascular effects of calcium channel blocking agents: potential mechanisms.

Millard RW, Lathrop DA, Grupp G, Ashraf M, Grupp IL, Schwartz A.

Am J Cardiol. 1982 Feb 18;49(3):499-506.

PMID:
6277175
41.

Mechanism of action of digitalis: is the Na,K-ATPase the pharmacological receptor?

Schwartz A, Whitmer K, Grupp G, Grupp I, Adams RJ, Lee SW.

Ann N Y Acad Sci. 1982;402:253-71. No abstract available.

PMID:
6301334
42.

Effects of very low concentrations of ouabain on contractile force of isolated guinea-pig, rabbit and cat atria and right ventricular papillary muscles: an interinstitutional study.

Grupp G, Grupp IL, Ghysel-Burton J, Godfraind T, Schwartz A.

J Pharmacol Exp Ther. 1982 Jan;220(1):145-51. No abstract available.

PMID:
6273527
43.

Digitalis receptor desensitization in rat ventricle: ouabain produces two inotropic effects.

Grupp IL, Grupp G, Schwartz A.

Life Sci. 1981 Dec 28;29(26):2789-94. No abstract available.

PMID:
7329206
44.

Interaction of chlormadinone acetate with the ouabain binding site of Na+,K+-ATPase.

Wehling M, Schwartz A, Whitmer K, Grupp G, Grupp IL, Wallick ET.

Mol Pharmacol. 1981 Nov;20(3):551-7. No abstract available.

PMID:
6173736
45.

Lack of effect of neuraminidase on responses of isolated guinea-pig heart preparations to ouabain.

Grupp G, Grupp I, Schwartz A.

J Mol Cell Cardiol. 1980 Dec;12(12):1471-4. No abstract available.

PMID:
7205961
46.

Effects of RMI 12330A, a new inhibitor of adenylate cyclase on myocardial function and subcellular activity.

Grupp G, Grupp IL, Johnson CL, Matlib MA, Rouslin W, Schwartz A, Wallick ET, Wang T, Wisler P.

Br J Pharmacol. 1980 Nov;70(3):429-42.

47.

Effects of vanadate on biochemical and contractile properties of rabbit hearts.

Solaro RJ, Holroyde MJ, Wang T, Matlib MA, Grupp I, Grupp G, Schwartz A.

J Cardiovasc Pharmacol. 1980 Jul-Aug;2(4):445-52. No abstract available.

PMID:
6156342
48.

Direct vasodilator and positive inotropic actions of amrinone.

Millard RW, Dubé G, Grupp G, Grupp I, Alousi A, Schwartz A.

J Mol Cell Cardiol. 1980 Jun;12(6):647-52. No abstract available.

PMID:
7452740
49.

Hemodynamic and myocardial consequences of scorpion venom.

Gueron M, Adolph RJ, Grupp IL, Gabel M, Grupp G, Fowler NO.

Am J Cardiol. 1980 May;45(5):979-86. No abstract available.

PMID:
7369148
50.

Effects of vanadate on myocardial function.

Schwartz A, Adams RJ, Grupp I, Grupp G, Holroyde MJ, Millard RW, Solaro RJ, Wallick ET.

Basic Res Cardiol. 1980 May-Jun;75(3):444-51. No abstract available.

PMID:
6449925

Supplemental Content

Support Center